GeoVax Labs has partnered with Leidos on an effort to develop anti-malaria vaccines in support of the United States Agency for International Development. The companies will work to deliver vaccine candidates that combat P. falciparum malaria under USAID's Malaria Vaccine Development Program, GeoVax said Monday.
VLP Therapeutics has received a $2.4 million grant from the U.S. Army to research and develop a vaccine against malaria. The service branch awarded the research grant through the Defense Department's Peer Reviewed Medical Research Program, the company said Thursday. Wataru Akahata, founder and CEO of VLP Therapeutics, said the company has developed VLPM01, an experimental […] More